Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

December 30, 2018

Pretreating Ocrevus Patients with Multiple Antihistamines and Liquids Lowers Infusion Reactions by 60%, Study Reports

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Ocrevus
    /
December 18, 2018 Pretreating multiple sclerosis patients with antihistamines more extensively and with hydration can significantly reduce — by 60% — the likelihood…
MS Drug Therapies

December 30, 2018

Spasticity Improved With Cannabinoid Oral Spray

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Nancy A. Melville – December 24, 2018 Nabiximols, a cannabinoid-based oral spray (Sativex, GW Pharmaceuticals) approved outside the United States for various multiple…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

December 29, 2018

New stem cell research reveals what prevents remyelination

  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
Dec 19, 2018 New research on remyelination could lead to a novel approach to developing treatments for multiple sclerosis. The…
Multiple Sclerosis

December 29, 2018

Study uncovers potential risks of common MS treatment

  • MS Research Study and Reports
    /
In one of the most comprehensive studies to date, University of British Columbia researchers found an increased risk of events…
MS Research Study and Reports

December 28, 2018

It’s never too late to make a difference

  • FUNDRAISING
    /
  • MS Views and News
    /
  • Multiple Sclerosis
    /
With the help of many  MS Views and News accomplished so much in 2018. Please click the arrow on the…
FUNDRAISING

December 28, 2018

Cladribine (also known as Mavenclad™)

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Experimental Medications: Administered Orally Company: Merck Oral medication taken for a maximum of 20 days over two years Being studied…
MS Drug Therapies

December 28, 2018

TAKING A CLOSER LOOK AT THE KEY PLAYERS IN MS

  • Multiple Sclerosis
    /
Understanding how the innate and adaptive  immune systems communicate through different players may help deepen our understanding of what causes MS and…
Multiple Sclerosis

December 28, 2018

THE SCIENCE OF MS IS STILL UNDER CONSTRUCTION

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
We’re breaking down the science behind the condition to reconstruct a new understanding of MS that may build a better…
MS Drug Therapies

December 28, 2018

Australia MS News: Expensive MS drug (Mavenclad) to be on PBS next year

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
A drug used to treat people with multiple sclerosis has been added to the Pharmaceutical Benefits Scheme. www.9news.com.au  · Dec…
MS Drug Therapies

December 28, 2018

GB Sciences, LSU Partner on Cannabinoid Research and Development Project for MS, Other Diseases

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Dec 12, 2018 As debate continues about the effects of medical marijuana on multiple sclerosis (MS) and other diseases, cannabis company GB Sciences and Louisiana…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

Categories

Latest Blog Posts